Pharmaceutical Preparation Manufacturing contractors at the Department of Defense
- Latest 12 months
- $65.6M
- Net obligations · Down $44.2M vs. $109.8M preceding
- Prime contractors
- 78
- With positive obligations in the latest 12 months
Market snapshot for Pharmaceutical Preparation Manufacturing at the Department of Defense
Federal records show $26.3B in net obligations across 80,663 awards in Pharmaceutical Preparation Manufacturing at the Department of Defense from Oct 1, 2021 through Jul 27, 2026. This market accounts for 1.2% of $2.1T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 40.3% from $109.8M to $65.6M. 7 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY26 is year-to-date through Jul 27, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $24.0B | 18,496 | Complete |
| FY2023 | $2.0B | 16,837 | Complete |
| FY2024 | $116.4M | 17,387 | Complete |
| FY2025 | $88.9M | 23,689 | Complete |
| FY2026 | $52.4M | 9,034 | YTD through Jul 27, 2026 |
Market at a glance
All reported prime contract awards- All-period net obligations
- $26.3B
- 80,663 awards · 217 prime contractors
- Latest 12-month movement
- −40.3%
- $65.6M vs. $109.8M
- Leading eight prime share
- 82.6%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 1.2% of $2.1T in agency-wide net obligations.
- Set-aside share when reported
- 0.9% of 11,762 awards with reported set-aside status.
- Set-aside reporting
- 110 set aside · 11,652 no set-aside · 68,901 not reported
What changed in the last 12 months?
Jul 28, 2025–Jul 27, 2026, compared with Jul 28, 2024–Jul 27, 2025.
Competitive shifts
TEVA PHARMACEUTICALS USA, INC. gained the most market share
CANADIAN COMMERCIAL CORPORATION lost the most market share
KAPLAN INDUSTRIES, INC. fell the most in the contractor rankings
SIGA TECHNOLOGIES, INC. had no reported activity in the latest 12 months
Buyer demand
Reported obligations through DLA TROOP SUPPORT decreased
View 1 additional material change
Buyer demand
Reported obligations through AMC BAMC FSH - MM increased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Funding pattern for Pharmaceutical Preparation Manufacturing at the Department of Defense
See how positive obligations were attributed across funding offices in the 12 months ending Jul 27, 2026.
47.9% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2DP). That represents $31.4M, down $16.2M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- DLA TROOP SUPPORT (SPE2DP)47.9% · $31.4M · down $16.2M
- DLA TROOP SUPPORT (SPE2D6)17.2% · $11.3M · down $17.5M
- AMC BAMC FSH - MM9.0% · $5.9M · up $4.9M
- DLA TROOP SUPPORT (SPE2D0)4.8% · $3.2M · up $320K
- DIRECTOR, WRNMMC4.1% · $2.7M · down $299K
- All other reported offices17.0% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
DLA TROOP SUPPORT (SPE2DP)
#1Rank unchangedLatest 12 months
$31.4M
47.9% of positive obligations
Versus preceding 12 months
−$16.2M
36 active prime contractors · 6,203 awards
View office comparison and evidence
Reported obligations decreased 33.9% from $47.6M to $31.4M. The office’s share of positive obligations moved from 43.2% to 47.9%, a change of +4.7 percentage points.
The latest period contains 6,610 actions across 6,203 awards and 11 newly active prime contractors. The preceding period contained 34 active prime contractors and 14,854 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D6)
#2Rank unchangedLatest 12 months
$11.3M
17.2% of positive obligations
Versus preceding 12 months
−$17.5M
1 active prime contractor · 166 awards
View office comparison and evidence
Reported obligations decreased 60.7% from $28.7M to $11.3M. The office’s share of positive obligations moved from 26.1% to 17.2%, a change of −8.9 percentage points.
The latest period contains 168 actions across 166 awards. The preceding period contained 1 active prime contractor and 202 awards.
Leading award-level changes
- CANADIAN COMMERCIAL CORPORATION · PIID SPE2D624F2YLL−$6.1M: $6.1M → $0
- CANADIAN COMMERCIAL CORPORATION · PIID SPE2D624F2PRW−$5.7M: $5.7M → $0
Reported funding office
AMC BAMC FSH - MM
#3Up 7 from #10Latest 12 months
$5.9M
9.0% of positive obligations
Versus preceding 12 months
+$4.9M
14 active prime contractors · 22 awards
View office comparison and evidence
Reported obligations increased 478.3% from $1.0M to $5.9M. The office’s share of positive obligations moved from 0.93% to 9.0%, a change of +8.1 percentage points.
The latest period contains 51 actions across 22 awards and 3 newly active prime contractors. The preceding period contained 17 active prime contractors and 25 awards.
Leading award-level changes
- NOVARTIS PHARMACEUTICALS CORPORATION · PIID W81K0025FA195+$3.2M: $0 → $3.2M
- CARDINAL HEALTH 414, LLC · PIID W81K0024F0127−$1.0M: $1.0M → $0
Reported funding office
DLA TROOP SUPPORT (SPE2D0)
#4Up 2 from #6Latest 12 months
$3.2M
4.8% of positive obligations
Versus preceding 12 months
+$320K
6 active prime contractors · 27 awards
View office comparison and evidence
Reported obligations increased 11.2% from $2.9M to $3.2M. The office’s share of positive obligations moved from 2.6% to 4.8%, a change of +2.2 percentage points.
The latest period contains 27 actions across 27 awards. The preceding period contained 7 active prime contractors and 71 awards.
Reported funding office
DIRECTOR, WRNMMC
#5Rank unchangedLatest 12 months
$2.7M
4.1% of positive obligations
Versus preceding 12 months
−$299K
11 active prime contractors · 14 awards
View office comparison and evidence
Reported obligations decreased 10.1% from $3.0M to $2.7M. The office’s share of positive obligations moved from 2.7% to 4.1%, a change of +1.4 percentage points.
The latest period contains 15 actions across 14 awards and 3 newly active prime contractors. The preceding period contained 10 active prime contractors and 18 awards.
Reported funding office
AMC BEAUMONT BLISS - MM
#6Up 3 from #9Latest 12 months
$2.1M
3.2% of positive obligations
Versus preceding 12 months
+$1.0M
8 active prime contractors · 10 awards
View office comparison and evidence
Reported obligations increased 93.8% from $1.1M to $2.1M. The office’s share of positive obligations moved from 0.98% to 3.2%, a change of +2.2 percentage points.
The latest period contains 23 actions across 10 awards and 3 newly active prime contractors. The preceding period contained 7 active prime contractors and 9 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D9)
#7Up 1 from #8Latest 12 months
$1.2M
1.9% of positive obligations
Versus preceding 12 months
−$538K
1 active prime contractor · 5,898 awards
View office comparison and evidence
Reported obligations decreased 30.4% from $1.8M to $1.2M. The office’s share of positive obligations moved from 1.6% to 1.9%, a change of +0.3 percentage points.
The latest period contains 5,898 actions across 5,898 awards. The preceding period contained 1 active prime contractor and 4,588 awards.
Reported funding office
KIMBROUGH AMB CC MEADE - MM
#8Down 1 from #7Latest 12 months
$1.2M
1.8% of positive obligations
Versus preceding 12 months
−$919K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations decreased 44.0% from $2.1M to $1.2M. The office’s share of positive obligations moved from 1.9% to 1.8%, a change of −0.1 percentage points.
The latest period contains 5 actions across 3 awards. The preceding period contained 3 active prime contractors and 8 awards.
Reported funding office
NAV MED CNT PORTSMOUTH VA - MM
#9Up 5 from #14Latest 12 months
$1.0M
1.6% of positive obligations
Versus preceding 12 months
+$365K
4 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 53.4% from $683K to $1.0M. The office’s share of positive obligations moved from 0.62% to 1.6%, a change of +1.0 percentage points.
The latest period contains 10 actions across 5 awards. The preceding period contained 4 active prime contractors and 6 awards.
Reported funding office
AMC TRIPLER SHAFTER - MM
#10Up 1 from #11Latest 12 months
$659K
1.0% of positive obligations
Versus preceding 12 months
−$349K
5 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations decreased 34.6% from $1.0M to $659K. The office’s share of positive obligations moved from 0.91% to 1.0%, a change of +0.1 percentage points.
The latest period contains 22 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 6 active prime contractors and 9 awards.
Reported funding office
NAV MED CTR SAN DIEGO CA - MM
#11Up 11 from #22Latest 12 months
$554K
0.84% of positive obligations
Versus preceding 12 months
+$283K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations increased 104.4% from $271K to $554K. The office’s share of positive obligations moved from 0.25% to 0.84%, a change of +0.6 percentage points.
The latest period contains 5 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 4 awards.
Reported funding office
W6DZ CPE CBRND FT DETRICK
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$10.2M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $10.2M to $0. The office’s share of positive obligations moved from 9.3% to 0%, a change of −9.3 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.
Reported funding office
W2DN BROOKE AMC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$3.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $3.8M to $0. The office’s share of positive obligations moved from 3.5% to 0%, a change of −3.5 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 3 active prime contractors and 3 awards.
How this work is bought
Reported award structure, competition, pricing, work categories, and contracting channels for Pharmaceutical Preparation Manufacturing at the Department of Defense.
During Jul 28, 2025–Jul 27, 2026, this market recorded $66.4M in positive net award obligations across 11,757 awards. The leading reported procedure, Only One Source, accounted for 69.3% of that positive-obligation base. Awards with a reported parent IDV accounted for 84.5%.
- Leading award type
- 81.5%
- Delivery Order
- Leading reported procedure
- 69.3%
- Only One Source
- Reported parent IDV
- 84.5%
- of positive obligations had a reported parent IDV
- Median reported offers
- 2
- 1,486 of 11,757 awards reported offers · Limited reporting
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 13.5 percentage points lower, reported full-and-open obligation share is 85.0 percentage points lower, delivery-order obligation share is 16.3 percentage points lower, and median positive award obligations are 99.9% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 84.5% | 98.0% | -13.5 pts |
| Reported full-and-open obligation share | 12.7% | 97.7% | -85.0 pts |
| Delivery-order obligation share | 81.5% | 97.8% | -16.3 pts |
| Median positive award obligations | $55 | $60K | -99.9% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Health and Human Services (HHS)
- Department of Justice (DOJ)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 10,281 | $54.1M | 81.5% |
| Purchase Order(B) | 1,443 | $9.4M | 14.2% |
| BPA Call(A) | 30 | $2.0M | 3.0% |
| Definitive Contract(D) | 3 | $861K | 1.3% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 10,270 | $53.1M | 80.0% |
| BPA(E) | 30 | $2.0M | 3.0% |
| FSS(C) | 11 | $994K | 1.5% |
| Not reported | 1,446 | $10.3M | 15.5% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 10,300 | $55.2M | 83.0% |
| Multiple Award(M) | 11 | $994K | 1.5% |
| Not reported | 1,446 | $10.3M | 15.5% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source(SSS) | 208 | $46.0M | 69.3% |
| Simplified Acquisition(SP1) | 1,508 | $11.9M | 17.9% |
| Negotiated Proposal/Quote(NP) | 10,029 | $7.3M | 10.9% |
| Subject To Multiple Award Fair Opportunity(MAFO) | 12 | $1.2M | 1.9% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not Competed(C) | 44 | $34.7M | 52.3% |
| Not Available For Competition(B) | 164 | $11.3M | 17.0% |
| Full And Open Competition(A) | 10,040 | $8.4M | 12.7% |
| Competed Under SAP(F) | 1,407 | $6.1M | 9.2% |
| Not Competed Under SAP(G) | 101 | $5.8M | 8.7% |
| Full And Open Competition After Exclusion Of Sources(D) | 1 | $65K | 0.10% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 7 | $782K | 1.2% |
| Other Statutory Authority(OSA) | 1 | $245K | 0.37% |
| Fair Opportunity Given(FAIR) | 2 | $180K | 0.27% |
| FAR 16.505(B)(2)(I)(G) Single Source(SSRC) | 1 | $20K | 0.030% |
| FAR 16.505(B)(2)(I)(G) Limited Sources(LSRC) | 1 | $15K | 0.020% |
| Not reported | 11,745 | $65.2M | 98.1% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 207 | $45.8M | 69.0% |
| SAP Non-Competition (FAR 13)(SP2) | 100 | $5.6M | 8.4% |
| Authorized By Statute (FAR 6.302-5(A)(2)(I))(OTH) | 1 | $182K | 0.27% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $177K | 0.27% |
| Not reported | 11,448 | $14.6M | 22.0% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 11,757 | $66.4M | 100.0% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs And Biologicals(6505) | 11,380 | $61.1M | 92.0% |
| Medical And Surgical Instruments, Equipment, And Supplies(6515) | 81 | $1.6M | 2.4% |
| Laboratory Equipment And Supplies(6640) | 6 | $1.2M | 1.9% |
| In Vitro Diagnostic Substances, Reagents, Test Kits And Sets(6550) | 87 | $1.1M | 1.6% |
| Pharmacy Services(Q517) | 9 | $508K | 0.77% |
| Medical- Radiology(Q522) | 1 | $262K | 0.40% |
| Other reported values | 193 | $631K | 0.95% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Defense Logistics Agency(97AS) | 11,637 | $48.6M | 73.1% |
| Department of the Army(2100) | 64 | $11.7M | 17.7% |
| Defense Health Agency(97DH) | 50 | $5.8M | 8.8% |
| Department of the Air Force(5700) | 5 | $266K | 0.40% |
| U.S. Special Operations Command(97ZS) | 1 | $7K | 0.010% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Dla Troop Support(SPE2DP) | 4,426 | $32.2M | 48.5% |
| Dla Troop Support(SPE2D6) | 164 | $11.3M | 17.0% |
| W40m Mrc0 West(W81K00) | 40 | $9.3M | 14.0% |
| Dla Troop Support(SPE2D0) | 6 | $3.2M | 4.8% |
| Defense Health Agency(HT0014) | 13 | $2.7M | 4.0% |
| W40m Usa Hca(W81K04) | 14 | $1.5M | 2.3% |
| Other reported values | 7,094 | $6.3M | 9.5% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SPE2DP20D0002(9700) | 32 | $29.2M | 44.0% |
| SPE2DP23D0001(9700) | 164 | $11.3M | 17.0% |
| W81K0024D0004(9700) | 1 | $3.2M | 4.9% |
| SPE2D021D0008(9700) | 35 | $1.8M | 2.7% |
| SPE2DX25D8022(9700) | 5,631 | $1.2M | 1.9% |
| SPE2DP21D0002(9700) | 3 | $1.2M | 1.8% |
| SPE2D020D0014(9700) | 978 | $1.1M | 1.7% |
| SPE2DX15D9383(9700) | 3,121 | $1.1M | 1.6% |
| Other reported values | 346 | $6.0M | 9.1% |
| Not reported | 1,446 | $10.3M | 15.5% |
Exactly matched vehicle usage
$22K · 0.030%
1 awards matched an unambiguous catalog vehicle PIID. Company membership is not used as evidence of award-channel usage.
Offers, award size, and timing
- Median reported offers
- 2 median
- 1,486 reported · 10,271 not reported · Limited reporting
- Positive award obligations
- $55 median
- $17–$208 middle 50%
- Reported performance period
- 1 day median
- 11,757 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Jul 27, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Prime contractors for Pharmaceutical Preparation Manufacturing at the Department of Defense
Latest 12-month concentration and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 7 of 78prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 44.5%of positive obligations in the last 12 months
- Leading four prime contractors
- 74.6%of positive obligations in the last 12 months
- Leading eight prime contractors
- 82.6%of positive obligations in the last 12 months
Based on $65.6M in positive obligations during the 12 months ending Jul 27, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Jul 28, 2024–Jul 27, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$29.2M
44.5%
Dollar movement
−$11.0M
vs. prior 12 months
Last 12mo awards
32 awards
32 actions
Historical and award details for TEVA PHARMACEUTICALS USA, INC.
- Obligations: prior → latest
- $40.2M → $29.2M
- −27.4%
- Share: prior → latest
- 36.2% → 44.5%
- +8.3 percentage points
- All-period obligations
- $172.4M
- 0.66% of all-period positive obligations · 332 awards
- Recorded activity
- Since Nov 9, 2021
- through Apr 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 32 72 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$12.3M
18.8%
Dollar movement
−$17.3M
vs. prior 12 months
Last 12mo awards
170 awards
172 actions
Historical and award details for CANADIAN COMMERCIAL CORPORATION
- Obligations: prior → latest
- $29.7M → $12.3M
- −58.5%
- Share: prior → latest
- 26.7% → 18.8%
- −7.9 percentage points
- All-period obligations
- $110.8M
- 0.42% of all-period positive obligations · 1,034 awards
- Recorded activity
- Since Oct 6, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 170 206 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$4.7M
7.2%
Dollar movement
+$4.7M
vs. prior 12 months
Last 12mo awards
5 awards
8 actions
Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations: prior → latest
- $23K → $4.7M
- +19911.4%
- Share: prior → latest
- 0.020% → 7.2%
- +7.1 percentage points
- All-period obligations
- $4.7M
- 0.020% of all-period positive obligations · 6 awards
- Recorded activity
- Since Jul 1, 2025
- through Feb 11, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 0 Not reported 2 1 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$2.7M
4.1%
Dollar movement
−$739K
vs. prior 12 months
Last 12mo awards
21 awards
33 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $3.4M → $2.7M
- −21.5%
- Share: prior → latest
- 3.1% → 4.1%
- +1.0 percentage points
- All-period obligations
- $14.5M
- 0.060% of all-period positive obligations · 77 awards
- Recorded activity
- Since Oct 6, 2021
- through Apr 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 15 13 Not reported 6 3 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$1.8M
2.7%
Dollar movement
+$1.2M
vs. prior 12 months
Last 12mo awards
35 awards
35 actions
Historical and award details for AMERICAN REGENT INC
- Obligations: prior → latest
- $640K → $1.8M
- +181.2%
- Share: prior → latest
- 0.58% → 2.7%
- +2.2 percentage points
- All-period obligations
- $3.6M
- 0.010% of all-period positive obligations · 154 awards
- Recorded activity
- Since Mar 28, 2022
- through Apr 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 35 43 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.2M
1.9%
Dollar movement
−$538K
vs. prior 12 months
Last 12mo awards
5,898 awards
5,898 actions
Historical and award details for CARDINAL HEALTH, INC.
- Obligations: prior → latest
- $1.8M → $1.2M
- −30.4%
- Share: prior → latest
- 1.6% → 1.9%
- +0.3 percentage points
- All-period obligations
- $7.6M
- 0.030% of all-period positive obligations · 24,516 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 5,898 4,588 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$1.2M
1.8%
Dollar movement
+$108K
vs. prior 12 months
Last 12mo awards
1 award
3 actions
Historical and award details for JUBILANT HOLLISTERSTIER LLC
- Obligations: prior → latest
- $1.0M → $1.2M
- +10.3%
- Share: prior → latest
- 0.94% → 1.8%
- +0.8 percentage points
- All-period obligations
- $3.1M
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 29, 2023
- through Apr 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$1.1M
1.7%
Dollar movement
−$154K
vs. prior 12 months
Last 12mo awards
978 awards
978 actions
Historical and award details for PFIZER INC
- Obligations: prior → latest
- $1.3M → $1.1M
- −12.2%
- Share: prior → latest
- 1.1% → 1.7%
- +0.6 percentage points
- All-period obligations
- $16.6B
- 63.1% of all-period positive obligations · 3,651 awards
- Recorded activity
- Since Oct 4, 2021
- through Apr 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 978 616 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$1.1M
1.6%
Dollar movement
+$494K
vs. prior 12 months
Last 12mo awards
6 awards
14 actions
Historical and award details for LANTHEUS MEDICAL IMAGING, INC.
- Obligations: prior → latest
- $561K → $1.1M
- +88.0%
- Share: prior → latest
- 0.51% → 1.6%
- +1.1 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 32 awards
- Recorded activity
- Since Oct 7, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 1 Reported no set-aside 2 4 Not reported 2 4 Reported small business 5 6 All-period set-aside types
- 3 · Total small business
- #10
Last 12mo obligations
$883K
1.4%
Dollar movement
+$451K
vs. prior 12 months
Last 12mo awards
2 awards
5 actions
Historical and award details for BRACCO DIAGNOSTICS INC.
- Obligations: prior → latest
- $432K → $883K
- +104.2%
- Share: prior → latest
- 0.39% → 1.4%
- +1.0 percentage points
- All-period obligations
- $1.7M
- 0.010% of all-period positive obligations · 6 awards
- Recorded activity
- Since Dec 15, 2021
- through Dec 15, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$848K
1.3%
Dollar movement
+$63K
vs. prior 12 months
Last 12mo awards
9 awards
19 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $785K → $848K
- +8.1%
- Share: prior → latest
- 0.71% → 1.3%
- +0.6 percentage points
- All-period obligations
- $3.2M
- 0.010% of all-period positive obligations · 26 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 3, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 9 4 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$831K
1.3%
Dollar movement
−$3.2M
vs. prior 12 months
Last 12mo awards
4,883 awards
5,275 actions
Historical and award details for DMS PHARMACEUTICAL GROUP INC
- Obligations: prior → latest
- $4.0M → $831K
- −79.2%
- Share: prior → latest
- 3.6% → 1.3%
- −2.3 percentage points
- All-period obligations
- $10.2M
- 0.040% of all-period positive obligations · 36,880 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 23, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 5 Reported no set-aside 39 31 Not reported 4,843 11,879 Reported small business 4,883 11,915 All-period set-aside types
- 7 · Total small business
- #13
Last 12mo obligations
$802K
1.2%
Dollar movement
+$21K
vs. prior 12 months
Last 12mo awards
5 awards
13 actions
Historical and award details for BOSTON SCIENTIFIC CORP
- Obligations: prior → latest
- $781K → $802K
- +2.7%
- Share: prior → latest
- 0.70% → 1.2%
- +0.5 percentage points
- All-period obligations
- $4.0M
- 0.020% of all-period positive obligations · 19 awards
- Recorded activity
- Since Oct 27, 2021
- through Apr 8, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 3 3 Not reported 2 3 Reported small business 0 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
$546K
0.83%
Dollar movement
−$644K
vs. prior 12 months
Last 12mo awards
7 awards
9 actions
Historical and award details for SOFIE CO.
- Obligations: prior → latest
- $1.2M → $546K
- −54.1%
- Share: prior → latest
- 1.1% → 0.83%
- −0.2 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 57 awards
- Recorded activity
- Since Oct 1, 2021
- through Feb 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 7 13 Not reported 0 0 Reported small business 0 2 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$531K
0.81%
Dollar movement
+$401K
vs. prior 12 months
Last 12mo awards
3 awards
7 actions
Historical and award details for AMERICAN NATIONAL SERVICES LLC
- Obligations: prior → latest
- $129K → $531K
- +310.2%
- Share: prior → latest
- 0.12% → 0.81%
- +0.7 percentage points
- All-period obligations
- $2.5M
- 0.010% of all-period positive obligations · 9 awards
- Recorded activity
- Since Nov 5, 2021
- through Apr 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 1 Reported no set-aside 0 0 Not reported 1 2 Reported small business 3 3 All-period set-aside types
- 2 · Total small business
Award activity for Pharmaceutical Preparation Manufacturing at the Department of Defense
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$3.2M
NOVARTIS PHARMACEUTICALS CORPORATION
AMC BAMC FSH - MM
LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.
Why it stands out
The contractor climbed 53 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $3.2M
- Share of 12-month positive obligations
- 4.8%
Supporting data
- Prime contractor
- #3 · 7.2% share
- up 53 ranks · +7.1 percentage points · $4.7M net increase; action accounted for 68.0%
- Funding office
- #3 · 9.0% attributed share
- up 7 ranks · +8.1 percentage points · $4.9M net increase; action accounted for 64.8%
This action
+$5.2M
CANADIAN COMMERCIAL CORPORATION
DLA TROOP SUPPORT
4571290114!REACTIVE SKIN DECONTAMINATION LOTION
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 7.9% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $17.3M overall.
- Award net obligations
- $5.2M
- Share of 12-month positive obligations
- 7.9%
Supporting data
- Prime contractor
- #2 · 18.8% share
- $17.3M net decline despite this positive action
- Funding office
- #2 · 17.2% attributed share
- $17.5M net decline despite this positive action
This action
+$1.8M
AMERICAN REGENT INC
DLA TROOP SUPPORT
8511647514!OTHER MEDICAL
Why it stands out
The contractor climbed 16 positions in this market.
It now ranks #5 by positive obligations over the latest 12 months.
- Award net obligations
- $1.8M
- Share of 12-month positive obligations
- 2.7%
Supporting data
- Prime contractor
- #5 · 2.7% share
- up 16 ranks · +2.2 percentage points · $1.2M net increase; action exceeded it by $617K
This action
+$4.0M
TEVA PHARMACEUTICALS USA, INC.
DLA TROOP SUPPORT
8511984334!ADENOVIRUS TYPE 4 A
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 6.0% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $11.0M overall.
- Award net obligations
- $4.0M
- Share of 12-month positive obligations
- 6.0%
Supporting data
- Prime contractor
- #1 · 44.5% share
- $11.0M net decline despite this positive action
- Funding office
- #1 · 47.9% attributed share
- $16.2M net decline despite this positive action
This action
+$864K
JUBILANT HOLLISTERSTIER LLC
KIMBROUGH AMB CC MEADE - MM
ANTIVENOM IMMUNOTHERAPY SUPPLIES
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $864K while office-attributed obligations fell $919K overall.
- Award net obligations
- $3.1M
- Share of 12-month positive obligations
- 1.3%
Supporting data
- Funding office
- #8 · 1.8% attributed share
- $919K net decline despite this positive action
This action
+$787K
PFIZER INC
DLA TROOP SUPPORT
8511599130!OTHER MEDICAL
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 1.2% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $154K overall.
- Award net obligations
- $787K
- Share of 12-month positive obligations
- 1.2%
Supporting data
- Prime contractor
- #8 · 1.7% share
- $154K net decline despite this positive action
View recent award activity by date (10)
- Action+$815Award net obligations$815
- Action+$19Award net obligations$19
- Action+$43KAward net obligations$43K
- Action+$270Award net obligations$270
- Action+$238Award net obligations$238
- Action+$99Award net obligations$99
- Action+$48Award net obligations$48
- Action+$41Award net obligations$41
- Action+$40Award net obligations$40
- Action+$35Award net obligations$35
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through July 27, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology